| [1] |
Shariff MI,Cox IJ,Gomaa AI, et al. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factor, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol, 2009, 3(4): 353-367.
|
| [2] |
Poon RT,Fan ST,Lo CM, et al. Improving survival results after resection of hepatocellualr carcinoma: a prospective study of 377 patients over 10 years. Ann Surg, 2001, 234(1): 63-70.
|
| [3] |
Arii S，Yamaoka Y，Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. the Liver Cancer Study Group of Japan. Hepatology, 2000, 32(6): 1224-1229.
|
| [4] |
Fong Y,Sun RL,Jarnagin W, et al. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg, 1999, 229(6): 790-799.
|
| [5] |
Grazi GL,Ercolani G,Pierangeli F, et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg, 2001, 234(1): 71-78.
|
| [6] |
Llovet JM,Fuster J,Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology, 1999, 30(6): 1434-1440.
|
| [7] |
Takayama T,Makuuchi M,Hirohashi S, et al. Early hepatocellualr carcinoma as an entity with a high rate of surgical cure. Hepatology, 1998, 28(5): 1241-1246.
|
| [8] |
Mazziotti A,Grazi GL,Cavellari A. Surgical treatment of hepatocellular carcinoma on cirrhosis: a Western experience. Hepatogastroenterology, 1998, 45(Suppl 3): 1281-1287.
|
| [9] |
Balsells J,Charco R,Lazaro JL, et al. Resection of hepatocellular carcinoma in patients with cirrhosis. Br J Surg, 1996, 83(6): 758-761.
|
| [10] |
Hashimoto T,Nakayama S,Fukkuhara T, et al. The state of recurrence and the role of hepatectomy in hepatocellular carcinoma. Hepatogastroenterology, 1994, 41(2): 144-149.
|
| [11] |
Adachi E,Maeda T,Matsumata T, et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology, 1995, 108(3): 768-775.
|
| [12] |
Nakamura H,Tanaka T,Hori S, et al. Transcatheter embolization of hepatocellular carcinoma: assessment of efficacy in cases of resection following embolization. Radiology, 1983, 147(2): 401-405.
|
| [13] |
Sakurai M,Okamura J,Kuroda C. Transcatheter chemo-embolization effective for treating hepatocellular carcinoma: a histopathologic study. Cancer, 1984, 54(3): 387-392.
|
| [14] |
Kanematsu T,Furuta T,Takenaka K, et al. A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology, 1989, 10(1): 98-102.
|
| [15] |
Okamura J,Horikawa S,Fujiyama T, et al. An appraisal of transcatheter arterial embolization combined with transcatheter arterial infusion of chemotherapeutic agent for hepatic malignancies. World J Surg, 1982, 6(3): 352-357.
|
| [16] |
Hwang TL,Chen MF,Lee TY, et al. Resection of hepatocellular carcinoma after transcatheter arterial embolization: reevaluation of the advantages and disadvantages of preoperative embolization. Arch Surg, 1987, 122(7): 756-759.
|
| [17] |
Wu CC,Ho YZ,Ho WL, et al. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg, 1995, 82(1): 122-126.
|
| [18] |
Yamasaki S,Hasegawa H,Kinoshita H, et al. A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res, 1996, 87(2): 206-211.
|
| [19] |
Tung-Ping Poon R,Fan ST,Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg, 2000, 232(1): 10-24.
|
| [20] |
Nonami T,Isshiki K,Katoh H, et al. The potential role of postoperative hepatic artery chemotherapy in patients with high-risk hepatomas. Ann Surg, 1991, 213(3): 222-226.
|
| [21] |
李锦清,张亚奇,张伟章,等.栓塞化疗在肝癌切除术后的价值.中华肿瘤杂志, 1994, 16(5): 387-389.
|
| [22] |
Takenaka K,Yoshida K,Nishizaki T, et al. Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma. Am J Surg, 1995, 169(4): 400-404.
|
| [23] |
Tanaka K,Shimada H,Togo S, et al. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection. Hepatogastroenterology, 1999, 46(26): 1083-1088.
|
| [24] |
Li JQ,Zhang YQ,Zhang WZ, et al. Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomy. J Cancer Res Clin Oncol, 1995, 121(6): 364-366.
|
| [25] |
Kohno H,Nagasue N,Hayashi T, et al. Postoperative adjuvant chemotherapy after radical hepatic resection for hepatocellular carcinoma (HCC). Hepatogastroenterology, 1996, 43(12): 1405-1409.
|
| [26] |
Ono T,Nagasue N,Kohno H, et al. Adjuvant chemotherapy with epirubicin and carmofur after radical resection of hepatocellular carcinoma: a prospective randomized study. Semin Oncol, 1997, 24(2 Suppl 6): S18-S25.
|
| [27] |
Lai EC,Lo CM,Fan ST, et al. Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg, 1998, 133(2): 183-188.
|
| [28] |
Ren ZG,Lin ZY,Xia JL, et al. Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study. World J Gastroenterol, 2004, 10(19): 2791-2794.
|
| [29] |
Izumi R,Shimizu K,Iyobe T, et al. Postoperative adjuvant hepatic arterial infusion of lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. Hepatology, 1994, 20(2): 295-301.
|
| [30] |
Ueno S,Tanabe G,Yoshida A, et al. Postoperative prediction of and strategy for metastatic recurrent hepatocellular carcinoma according to histologic activity of hepatitis. Cancer, 1999, 86(2): 248-254.
|
| [31] |
Peng BG,He Q,Li JP, et al. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Surg, 2009, 198(3): 313-318.
|
| [32] |
Liu Y,Yang R. Preoperative combined with postoperative chemoembolization can improve survival in patients with hepatocellular carcinoma: a single-center study. J Vasc Interv Radiol, 2009, 20(4): 472-483.
|
| [33] |
陆进,王卫东,徐平,等.肝动脉化疗栓塞对肝癌术后高危复发患者的疗效分析.现代消化及介入诊疗, 2011, 16(4): 239-241.
|
| [34] |
Shah SA,Greig PD,Gallinger S, et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg, 2006, 202(2): 275-283.
|
| [35] |
蔡健强,李聪,毕新宇.肝癌复发转移的防治策略.外科理论与实践, 2012, 17(5): 427-429.
|
| [36] |
陈晓泓,张博恒,殷欣,等.肝细胞癌根治术后行辅助性肝动脉化疗栓塞对近期复发的作用.中华医学杂志, 2010, 90(12): 826-829.
|
| [37] |
徐峰,黄杨卿,伍路,等.肝细胞癌根治性切除术后辅助性经导管肝动脉化疗栓塞价值的前瞻性研究.第二军医大学学报, 2012, 33(4): 390-394.
|
| [38] |
Kubo S,Nishiguchi S,Hirohashi K, et al. Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy. Br J Surg, 2002, 89(4): 418-422.
|
| [39] |
Liou TC,Shih SC,Kao CR, et al. Pulmonary metastasis of hepatocellular carcinoma associated with transarterial chemoembolization. J Hepatol, 1995, 23(5): 563-568.
|
| [40] |
Poste G,Fidler IJ. The pathogenesis of cancer metastasis. Nature, 1980, 283(5743): 139-146.
|
| [41] |
Fidler IJ,Balch CM. The biology of cancer metastasis and implications for therapy. Curr Probl Surg, 1987, 24(3): 129-209.
|
| [42] |
Yokoyama I,Carr B,Saitsu H, et al. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer, 1991, 68(10): 2095-2100.
|
| [43] |
Kwok PC,Lam TW,Lam PW, et al. Randomized controlled trial to compare the dose of adjuvant chemotherapy after curative resection of hepatocellular carcinoma. J Gastroenterol Hepatol, 2003, 18(4): 450-455.
|